Tech Center 1600 • Art Units: 1621 1626
This examiner grants 75% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18292092 | Compound and Method for Preparing Same | Non-Final OA | LG Energy Solution, Ltd. |
| 18145019 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | Non-Final OA | FUJIFILM Corporation |
| 18468356 | THIENOPYRIMIDINONE DERIVATIVES | Non-Final OA | Hoffmann-La Roche Inc. |
| 17220974 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | Final Rejection | Purdue Research Foundation |
| 18733551 | BROMODOMAIN INHIBITORS | Non-Final OA | AbbVie Inc. |
| 18183489 | ALKYL-LINKED POROUS PORPHYRIN POLYMER, AND METHOD OF SEPARATING GAS AND METHOD OF RECOVERING VALUABLE METAL USING SAME | Non-Final OA | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18044688 | INHIBITORS OF SPINSTER HOMOLOG 2 (SPNS2) FOR USE IN THERAPY | Final Rejection | Virginia Tech Intellectual Properties, Inc. |
| 18382280 | Treating Chronic Myelomonocytic Leukemia with CXCL8 Receptor Inhibitors | Non-Final OA | Institut National de la Sante et de la Recherche Medicale (INSERM) |
| 17788809 | 1,3-BUTYLENE GLYCOL PRODUCT | Non-Final OA | DAICEL CORPORATION |
| 18239728 | PHENANTHROLINE-BASED COMPOUND, METHOD OF PREPARING THE SAME AND PEROVSKITE SOLAR CELL COMPRISING THE SAME | Non-Final OA | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18254247 | METHOD OF PREPARING HETEROGENEOUS LINEAR CARBONATE USING ACIDIC ION EXCHANGE RESIN | Final Rejection | LOTTE CHEMICAL CORPORATION |
| 18549281 | CRYSTALLINE FORMS OF (4S)-24-CHLORO-4-ETHYL-73-FLUORO-35-METHOXY-32,5-DIOXO-14-(TRIFLUORO-METHYL)-32H-6-AZA-3(4,1)-PYRIDINA-1(1)-[1,2,3]TRIAZOLA-2(1,2),7(1)-DIBENZENAHEPTAPHANE-74-CARBOXAMIDE | Non-Final OA | Bayer Aktiengesellschaft |
| 17791684 | COMPLEXES OF N-HETEROCYCLIC CARBENES FOR TRANSITION METAL CATALYSIS | Non-Final OA | Rutgers, The State University of New Jersey |
| 18672226 | MEK INHIBITORS AND METHODS OF THEIR USE | Final Rejection | Exelixis, Inc. |
| 18001516 | SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA | Non-Final OA | Icahn School of Medicine At Mount Sinai |
| 18002535 | COMPOUNDS FOR SENSING REACTIVE OXYGEN SPECIES AND METHODS FOR USING THE SAME | Final Rejection | WAKE FOREST UNIVERSITY HEALTH SCIENCES |
| 18575799 | COMPOSITION COMPRISING HYDRANGENOL AS ACTIVE INGREDIENT FOR IMPROVING HAIR OR SCALP CONDITION | Non-Final OA | COSMAX BIO CO., LTD. |
| 18575643 | Heterocyclic compounds for the treatment of tuberculosis | Non-Final OA | TECNIMEDE - SOCIEDADE TÉCNICO-MEDICINAL, SA |
| 18037997 | PHOTO-CROSS-LINKING COPOLYMERIZED HYALURONIC ACID SPONGE AND PREPARATION METHOD THEREFOR | Non-Final OA | SNVIA CO., LTD. |
| 17949184 | COMPOUNDS AND METHODS FOR THE TREATMENT OF MICROBIAL INFECTIONS | Final Rejection | Versitech Limited |
| 17595519 | QUINOLINE DERIVATIVE USED FOR COMBINATION TREATMENT OF SMALL CELL LUNG CANCER | Non-Final OA | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. |
| 18560292 | AGELASTATIN A DERIVATIVES AND RELATED METHODS | Non-Final OA | Morgan JOUANNEAU |
| 18557300 | NITROGEN-CONTAINING HETEROCYCLIC PYRIDINE COMPOUND | Non-Final OA | SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. |
| 18370678 | SMALL MOLECULES FOR BORON NEUTRON CAPTURE THERAPY | Non-Final OA | Aviko Radiopharmaceuticals, LLC |
| 18548988 | 8-(PICOLINAMIDE) SUBSTITUTED COUMARIN COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Non-Final OA | LONGIVITRON (SUZHOU) BIOTECHNOLOGY CO., LTD |
| 16346028 | FUNCTIONAL DERIVATIVE COMPOUNDS OF ALANINE AND PROLINE AMINO ACIDS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Non-Final OA | AMTIXBIO CO., LTD. |
| 18274711 | METHOD FOR PRODUCING IMIDAZOPYRIDINE DERIVATIVE | Non-Final OA | TAGCYX BIOTECHNOLOGIES INC. |
| 18131963 | USE OF PENEHYCLIDINE IN TREATMENT OR PREVENTION OF VISION-IMPAIRING EYE DISEASES | Non-Final OA | GRAND LIFE SCIENCES GROUP (WUHAN) CO., LTD. |
| 18245978 | Amorphous Form of Isoquinoline Derivative | Non-Final OA | vTv Therapeutics LLC |
| 17919147 | WATER SOLUBLE FORMULATIONS CONTAINING CANNABINOIDS | Non-Final OA | MICILLIC LDA |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy